These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 20138162

  • 1. Influence of CGS 21680, a selective adenosine A(2A) receptor agonist, on NMDA receptor function and expression in the brain of Huntington's disease mice.
    Ferrante A, Martire A, Armida M, Chiodi V, Pézzola A, Potenza RL, Domenici MR, Popoli P.
    Brain Res; 2010 Apr 06; 1323():184-91. PubMed ID: 20138162
    [Abstract] [Full Text] [Related]

  • 2. Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice.
    Martire A, Calamandrei G, Felici F, Scattoni ML, Lastoria G, Domenici MR, Tebano MT, Popoli P.
    Neurosci Lett; 2007 Apr 24; 417(1):78-83. PubMed ID: 17331645
    [Abstract] [Full Text] [Related]

  • 3. Remodeling of striatal NMDA receptors by chronic A(2A) receptor blockade in Huntington's disease mice.
    Martire A, Ferrante A, Potenza RL, Armida M, Ferretti R, Pézzola A, Domenici MR, Popoli P.
    Neurobiol Dis; 2010 Jan 24; 37(1):99-105. PubMed ID: 19804830
    [Abstract] [Full Text] [Related]

  • 4. Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice.
    Domenici MR, Scattoni ML, Martire A, Lastoria G, Potenza RL, Borioni A, Venerosi A, Calamandrei G, Popoli P.
    Neurobiol Dis; 2007 Nov 24; 28(2):197-205. PubMed ID: 17720507
    [Abstract] [Full Text] [Related]

  • 5. Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.
    André VM, Cepeda C, Venegas A, Gomez Y, Levine MS.
    J Neurophysiol; 2006 Apr 24; 95(4):2108-19. PubMed ID: 16381805
    [Abstract] [Full Text] [Related]

  • 6. Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6/2 mouse model of Huntington's disease.
    Ali NJ, Levine MS.
    Dev Neurosci; 2006 Apr 24; 28(3):230-8. PubMed ID: 16679770
    [Abstract] [Full Text] [Related]

  • 7. Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
    Tebano MT, Pintor A, Frank C, Domenici MR, Martire A, Pepponi R, Potenza RL, Grieco R, Popoli P.
    J Neurosci Res; 2004 Jul 01; 77(1):100-7. PubMed ID: 15197743
    [Abstract] [Full Text] [Related]

  • 8. CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model.
    Chou SY, Lee YC, Chen HM, Chiang MC, Lai HL, Chang HH, Wu YC, Sun CN, Chien CL, Lin YS, Wang SC, Tung YY, Chang C, Chern Y.
    J Neurochem; 2005 Apr 01; 93(2):310-20. PubMed ID: 15816854
    [Abstract] [Full Text] [Related]

  • 9. The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system.
    Chiang MC, Chen HM, Lai HL, Chen HW, Chou SY, Chen CM, Tsai FJ, Chern Y.
    Hum Mol Genet; 2009 Aug 15; 18(16):2929-42. PubMed ID: 19443488
    [Abstract] [Full Text] [Related]

  • 10. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones.
    Nörenberg W, Wirkner K, Illes P.
    Br J Pharmacol; 1997 Sep 15; 122(1):71-80. PubMed ID: 9298530
    [Abstract] [Full Text] [Related]

  • 11. Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease.
    Ferrante A, Martire A, Pepponi R, Varani K, Vincenzi F, Ferraro L, Beggiato S, Tebano MT, Popoli P.
    Neurobiol Dis; 2014 Nov 15; 71():193-204. PubMed ID: 25132555
    [Abstract] [Full Text] [Related]

  • 12. Adenosine A2A receptor-induced inhibition of NMDA and GABAA receptor-mediated synaptic currents in a subpopulation of rat striatal neurons.
    Wirkner K, Gerevich Z, Krause T, Günther A, Köles L, Schneider D, Nörenberg W, Illes P.
    Neuropharmacology; 2004 Jun 15; 46(7):994-1007. PubMed ID: 15081796
    [Abstract] [Full Text] [Related]

  • 13. Adenosine A2A receptor antagonism increases nNOS-immunoreactive neurons in the striatum of Huntington transgenic mice.
    Cipriani S, Bizzoco E, Gianfriddo M, Melani A, Vannucchi MG, Pedata F.
    Exp Neurol; 2008 Sep 15; 213(1):163-70. PubMed ID: 18586241
    [Abstract] [Full Text] [Related]

  • 14. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
    Quarta D, Borycz J, Solinas M, Patkar K, Hockemeyer J, Ciruela F, Lluis C, Franco R, Woods AS, Goldberg SR, Ferré S.
    J Neurochem; 2004 Nov 15; 91(4):873-80. PubMed ID: 15525341
    [Abstract] [Full Text] [Related]

  • 15. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease.
    Dunah AW, Wang Y, Yasuda RP, Kameyama K, Huganir RL, Wolfe BB, Standaert DG.
    Mol Pharmacol; 2000 Feb 15; 57(2):342-52. PubMed ID: 10648644
    [Abstract] [Full Text] [Related]

  • 16. Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters.
    Estrada-Sánchez AM, Montiel T, Segovia J, Massieu L.
    Neurobiol Dis; 2009 Apr 15; 34(1):78-86. PubMed ID: 19168136
    [Abstract] [Full Text] [Related]

  • 17. Expression of adenosine A 2A receptors in the rat lumbar spinal cord and implications in the modulation of N-methyl-d-aspartate receptor currents.
    Guntz E, Dumont H, Pastijn E, d'Exaerde Ade K, Azdad K, Sosnowski M, Schiffmann SN, Gall D.
    Anesth Analg; 2008 Jun 15; 106(6):1882-9. PubMed ID: 18499627
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
    Pandis C, Sotiriou E, Kouvaras E, Asprodini E, Papatheodoropoulos C, Angelatou F.
    Neuroscience; 2006 Jun 19; 140(1):163-75. PubMed ID: 16542781
    [Abstract] [Full Text] [Related]

  • 19. Expression of N-methyl-d-aspartate (NMDA) receptor subunits and splice variants in an animal model of long-term voluntary alcohol self-administration.
    Raeder H, Holter SM, Hartmann AM, Spanagel R, Moller HJ, Rujescu D.
    Drug Alcohol Depend; 2008 Jul 01; 96(1-2):16-21. PubMed ID: 18358639
    [Abstract] [Full Text] [Related]

  • 20. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
    Li W, Silva HB, Real J, Wang YM, Rial D, Li P, Payen MP, Zhou Y, Muller CE, Tomé AR, Cunha RA, Chen JF.
    Neurobiol Dis; 2015 Jul 01; 79():70-80. PubMed ID: 25892655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.